Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16571960 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sugammadex ED90 Dose in the Obese Patients
Condition: Incomplete Reversal of Neuromuscular Block
Intervention: Drug: sugammadex ED90
2 Completed Sugammadex and Heart Failure
Condition: Postoperative Neuromuscular Block
Intervention: Drug: Sugammadex

Indicates status has not been verified in more than two years